Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for Negative Symptoms of Schizophrenia
NCT01032083Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citalopram in schizophrenia, sponsored by Imperial College London. Started Jul 2011; status: completed.
02
Drugs
citalopram
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01032083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032083.